Friday, 3 May 2019

Synthetic biology used to target cancer cells while sparing healthy tissue, study reports

Synthetic proteins engineered to recognize overly active biological pathways can kill cancer cells while sparing their healthy peers, according to a study by researchers at the Stanford University School of Medicine.

* This article was originally published here

Facebook considering its own bitcoin for payments

The Wall Street Journal reports that Facebook plans a cryptocurrency-based payment system that it could launch for billions of users worldwide.

* This article was originally published here

Blood pressure drug shows no benefit in Parkinson's disease

A study of a blood pressure drug does not show any benefit for people with Parkinson's disease, according to findings released today that will be presented at the American Academy of Neurology's 71st Annual Meeting in Philadelphia, May 4 to 10, 2019.

* This article was originally published here

Study shows why stomach pathogen is so tough to eradicate

The stomach-dwelling bacteria Helicobacter pylori survives in the stomach—a hellish, churning vat of hydrochloric acid—by holing up inside that organ's pitlike glands and establishing squatter's rights. Once the germ has set up shop, Stanford University School of Medicine investigators have learned, even competing strains of the same species can't displace it, or even share its hideout.

* This article was originally published here